Particularly, the investigation of the mechanism regulating the expression of its key characteristic transcription factor Foxp3 in digestive malignancies offers a broad array of supportive therapeutic targets and early diagnostic markers with predictive value for tumor diagnosis and treatment. This evidence concerns the gene FOXP3 and neoplasm.